Emergent BioSolutions (EBS) Tops Q2 EPS by $1.30, Raises Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. DOX
3. DUOL
4. ANET
5. CVS
6. BKNG
7. SWKS
8. AMGN
9. XYZ
10. FLYW

Go back to Emergent BioSolutions (EBS) Tops Q2 EPS by $1.30, Raises Guidance

Emergent BioSolutions Reports Financial Results for Second Quarter and Six Months Ended June 30, 2020 and Revises Upward Full Year 2020 Guidance

July 30, 2020 4:28 PM EDT

Establishes key collaborations with industry, U.S. government, and health care providers to help advance COVID-19 vaccine and therapeutic solutions
Current quarter and year-to-date performance reflect strength of core medical countermeasure business and increased impact of CDMO business

GAITHERSBURG, Md., July 30, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the three and six months ended June 30, 2020 and revised upward full year 2020 guidance.

While we mobilize to meet the threat presented by COVID-19, we are also successfully delivering on our long-term strategy, said Robert G. Kramer Sr.,... More